Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.
Mary D ChamberlinJason D WellsKevin SheeJennifer R BeanJonathan D MarottiWendy A WellsHeidi W TraskFred W KollingAnanta BhattPeter A KaufmanGary N SchwartzJohn M GemeryNancy J McNultyMichael J TsapakosRichard J BarthBradley A ArrickJiang GuiTodd W MillerPublished in: Breast cancer research and treatment (2020)
Subjects were prospectively enrolled in trial NCT01836640 (registered April 22, 2013).